New York, NY, United States of America

Dan Sherman



Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Dan Sherman: Innovator in Kinase Inhibition

Introduction

Dan Sherman is a notable inventor based in New York, NY (US), recognized for his contributions to the field of kinase inhibition. With a total of 4 patents, he has made significant strides in developing compounds that target specific kinases associated with various diseases.

Latest Patents

Among his latest patents, Sherman has developed inhibitors of CaMKK2, which provide compounds suitable for inhibiting this kinase. The disclosure includes compositions and methods for treating diseases associated with CaMKK2. Additionally, he has worked on macrocyclic kinase inhibitors, which involve compounds of specific formulas, including pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods for treating diseases, particularly cancers where FAK inhibition is beneficial.

Career Highlights

Throughout his career, Dan Sherman has worked with prominent organizations such as Osi Pharmaceuticals, Inc. and New York University. His work has focused on advancing the understanding and treatment of diseases through innovative approaches in kinase inhibition.

Collaborations

Some of his notable coworkers include Andrew Philip Crew and Hanqing Dong, who have contributed to his research endeavors.

Conclusion

Dan Sherman continues to be a significant figure in the field of kinase research, with his innovative patents paving the way for new treatments. His work exemplifies the impact of targeted therapies in modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…